Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Secondary cancers
Closed
Phase 1/2
This study is looking at a new drug called relatlimab to see how well it works alongside nivolumab for certain types of advanced cancer. It is for people whose cancer has spread elsewhere in the body and/or it can’t be removed by surgery.
Recruitment start: 14 December 2016
Recruitment end: 30 July 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Bristol-Myers Squibb
Last reviewed: 25 May 2022
CRUK internal database number: 15385